SummaryBackgroundThe necessary margin of excision for cutaneous melanomas greater than 2 mm in thickness is controversial. At a median follow-up of 5 years, findings from our previously published randomised trial of narrow (1 cm) versus wide (3 cm) excision margins in patients with thick cutaneous melanomas showed that narrow margins were associated with an increased frequency of locoregional relapse, but no significant difference in overall survival was apparent. We now report a long-term survival analysis of that trial.MethodsWe did a randomised, open-label multicentre trial in 59 hospitals—57 in the UK, one in Poland, and one in South Africa. Patients with one primary localised cutaneous melanoma greater than 2 mm in Breslow thickness on...
Background. The incidence of melanoma in situ (MIS) is increasing faster compared to invasive melano...
Background Guidelines for wide excision of cutaneous melanomas according to Breslow thickness are im...
Background: Reliable evidence to guide the management of melanoma in situ (MIS) and minimize the ris...
Background The necessary margin of excision for cutaneous melanomas greater than 2 mm in thickness i...
Background: In the past there has been controversy concerning the necessary margin of excision for c...
Background: The optimal surgical excision margins are uncertain for patients with thick (>2 mm) loca...
Background Optimum surgical resection margins for patients with clinical stage IIA-C cutaneous melan...
OBJECTIVE: This study was designed to determine the minimum safe pathologic excision margin for prim...
OBJECTIVE: To quantify the impact of excision margins on disease-specific survival of patients with ...
BACKGROUND Most guidelines recommend at least 2-cm excision margin for melanomas thicker than 2 m...
Although wide surgical excision is the accepted treatment for thin malignant melanomas, there is rea...
BackgroundThe current NCCN recommendation for resection margins in patients with melanomas between 1...
OBJECTIVE: To determine the optimum excision margin and nodal management for patients with primary c...
A quality-of-life study was carried out to test the hypothesis that melanoma patients treated with a...
2-cm and 4-cm surgical excision margins did not differ for survival in cutaneous melanoma> 2 mm t...
Background. The incidence of melanoma in situ (MIS) is increasing faster compared to invasive melano...
Background Guidelines for wide excision of cutaneous melanomas according to Breslow thickness are im...
Background: Reliable evidence to guide the management of melanoma in situ (MIS) and minimize the ris...
Background The necessary margin of excision for cutaneous melanomas greater than 2 mm in thickness i...
Background: In the past there has been controversy concerning the necessary margin of excision for c...
Background: The optimal surgical excision margins are uncertain for patients with thick (>2 mm) loca...
Background Optimum surgical resection margins for patients with clinical stage IIA-C cutaneous melan...
OBJECTIVE: This study was designed to determine the minimum safe pathologic excision margin for prim...
OBJECTIVE: To quantify the impact of excision margins on disease-specific survival of patients with ...
BACKGROUND Most guidelines recommend at least 2-cm excision margin for melanomas thicker than 2 m...
Although wide surgical excision is the accepted treatment for thin malignant melanomas, there is rea...
BackgroundThe current NCCN recommendation for resection margins in patients with melanomas between 1...
OBJECTIVE: To determine the optimum excision margin and nodal management for patients with primary c...
A quality-of-life study was carried out to test the hypothesis that melanoma patients treated with a...
2-cm and 4-cm surgical excision margins did not differ for survival in cutaneous melanoma> 2 mm t...
Background. The incidence of melanoma in situ (MIS) is increasing faster compared to invasive melano...
Background Guidelines for wide excision of cutaneous melanomas according to Breslow thickness are im...
Background: Reliable evidence to guide the management of melanoma in situ (MIS) and minimize the ris...